enGene Holdings is trading 6.79% higher at $1.73, alongside broad market strength as easing election uncertainty supported a market rebound. - No clear company-specific announcement was identified for November 4, 2026; its press-release page lists no releases on November 3 or 4. - Supplied market context shows major U.S. indices up more than 1.8%. - Biotech-sector strength was reported November 3, but its contribution today is unconfirmed.